Explore

Companies
Investors
Funds
Markets
Compare

Capbase

About
FAQ
Data & sources
Contribute

Compare

Crunchbase alternative
PitchBook alternative

Legal

Terms of Service
Privacy Policy
Takedown policy

Talapo Therapeutics — Funding, Investors & Profile — Capbase

← All companies

Compare History

Talapo Therapeutics

Private

Won 2 federal SBIR/STTR research awards from HHS and other federal agencies.

Department of Health and Human ServicesNational Institutes of Health

DUNS: 080328225

Founded: —Source: [GOV]
Headquarters: La Jolla, CaliforniaSource: [GOV]
Headcount: 1Source: [GOV]
Stage: Seed
Sector: Healthcare

$0Source: [GOV]Total raised

UndisclosedSource: [GOV]Last valuation

Overview

Talapo Therapeutics has been awarded 2 US Small Business Innovation Research (SBIR/STTR) contracts totalling $515,114 in 2018. These are non-dilutive federal research grants, not equity financing. The company is based in La Jolla, California.

Funding rounds

2 rounds

SBIR Phase I award (HHS)GrantMay 2018Source: [GOV]
$225K
—post-money
SBIR Phase I award (HHS)

Investors

No investors recorded yet for Talapo Therapeutics.

Add an investor

People

Leadership

DAVORKA MESSMERPrincipal investigatorSince 2018Source: [GOV]

Acquisitions

Talapo Therapeutics has no recorded acquisitions.

Add an acquisition

Exits

Still private — no exit on record.

Record an exit

Diversity investments

No diversity signals recorded yet for Talapo Therapeutics.

Add diversity data

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.

Grant

Sep 2018Source: [GOV]

$290.1K

—post-money